First-line treatments in WM
{"Image DocumentName": "First-line treatments in WM", "Image ImageDescription": "Stage. Fitness. Therapy. Standard. Alternatives ( trials) Smoldering. WM. Irrelevant. None. ? High risk patients???? Active disease. Fit. R+ chemo (RDC, R+purine analogs, RFC, R BENDA) R+ Bortezomib+Dexa. F, C , Bortezomib, Mab monotherapy. Autologous , allogeneic SCT. unfit. CLB. F. Dose-reduced FC, R BENDA, FCR ? CLB+R or CLB+O or CLB+GA101. MAb monotherapy (R, Ofatumumab, GA 101..)", "Image XResolution": "37", "Image YResolution": "37", "Image ResolutionUnit": "Pixels/Centimeter", "Image Software": "SlidePlayer", "Image YCbCrPositioning": "Centered"}